Koninklijke Philips | PHG - Sales Revenues


Koninklijke Philips reported EUR5.03B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Baxter International USD 2.84B 30M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Boston Scientific USD 5.29B 220M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Demant DKK 6.26B 810M Dec/2025
Dexcom USD 1.21B 50M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
General Electric Aerospace USD 11.87B 560M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 769M 23.7M Sep/2025
GN Store Nord DKK 4.68B 718M Dec/2025
Hitachi JPY 2.71T 180B Dec/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Koninklijke Philips EUR 5.03B 690.25M Sep/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 8.96B 383M Sep/2025
Philips EUR 4.3B 38M Sep/2025
ResMed USD 1.4B 100M Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Terumo JPY 274.97B 15B Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025